Treace Medical Concepts (Treace Medical Concepts) COGS-to-Revenue : 0.20 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Treace Medical Concepts COGS-to-Revenue?

Treace Medical Concepts's Cost of Goods Sold for the three months ended in Mar. 2024 was $10.1 Mil. Its Revenue for the three months ended in Mar. 2024 was $51.1 Mil.

Treace Medical Concepts's COGS to Revenue for the three months ended in Mar. 2024 was 0.20.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Treace Medical Concepts's Gross Margin % for the three months ended in Mar. 2024 was 80.19%.

Treace Medical Concepts COGS-to-Revenue Historical Data

The historical data trend for Treace Medical Concepts's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Treace Medical Concepts COGS-to-Revenue Chart

Treace Medical Concepts Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

0.19

0.22

0.18

0.19

Treace Medical Concepts Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial													0.19	0.18	0.20	0.18	0.20

Treace Medical Concepts COGS-to-Revenue Calculation

Treace Medical Concepts's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	35.181	/	187.118
	=	0.19

Treace Medical Concepts's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	10.127	/	51.108
	=	0.20

Treace Medical Concepts (NAS:TMCI) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Treace Medical Concepts's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	10.127 / 51.108
	=	80.19 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Treace Medical Concepts COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Treace Medical Concepts's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Treace Medical Concepts (Treace Medical Concepts) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Treace Medical Concepts Inc (NAS:TMCI) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081

Website

https://www.treace.com

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Executives

F Barry Bays	director
Betsy Hanna	director	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE RD #150, PONTE VEDRA BEACH FL 32081
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sean F. Scanlan	officer: See Remarks	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
James T Treace	director	117 BRISTOL PLACE, PONTE VEDRA BEACH FL 32082
Richard W Mott	director	1221 CROSSMAN AVENUE, SUNNYVALE CA 94089
Thomas E Timbie	director
Daniel E. Owens	officer: Chief HR Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Scot Michael Elder	officer: *See "Remarks"	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Mark Hair	officer: Chief Financial Officer	C/O RESTORATION ROBOTICS, INC., 128 BAYTECH DRIVE, SAN JOSE CA 95134
Aaron Berutti	officer: Sr. VP, Sales	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
John T. Treace	director, 10 percent owner, officer: Chief Executive Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Lance A Berry	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jane E Kiernan	director	525 W ROSCOE, CHICAGO IL 60657
John R Treace	director	5677 AIRLINE RD, ARLINGTON VA 38002